- Eurofins Scientific press release (OTCPK:ERFSF): FY Non-GAAP EPS of €3.37.
- Revenue of €6.95B (+6.6% Y/Y) and organically by 4.7%, setting a new record and exceeding Eurofins’ peak COVID-19 pandemic-driven revenue level.
- Adjusted EBITDA of €1,552m was 13.8% higher year-on-year and 67% higher than the €931m recorded before the COVID-19 pandemic